Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Pollard

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin|May 8, 2025
Enhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated PsychosisHadar Hazan, Maria Ferrara, Bin Zhou, et al.
BMC Psychiatry|December 5, 2014
Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED studyVinod H Srihari, Cenk Tek, Jessica Pollard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2024
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and DiagnosisHarrison K Tsai, Mark F Sabbagh, Meagan Montesion, et al.
Leukemia & Lymphoma|January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Clinical Epigenetics|October 17, 2017
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AMLLia Gore, Timothy J Triche, Jason E Farrar, et al.
Haematologica|June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Yimei Li, Marko Kavcic, et al.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Haematologica|February 1, 2024
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology GroupAndrew J Menssen, Chad A Hudson, Todd Alonzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2025
Genomic Profiling of Pediatric Mycosis Fungoides, Lymphomatoid Papulosis, and Primary Cutaneous Anaplastic Large Cell Lymphoma Identifies Recurrent Tyrosine Kinase Gene FusionsGrant M Fischer, Harrison K Tsai, Jennifer Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921Erica Brivio, Edoardo Pennesi, Marieke E Willemse, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin|May 8, 2025
Enhancing Coordinated Specialty Care Through Early Detection: Impact of Reduced Duration of Untreated PsychosisHadar Hazan, Maria Ferrara, Bin Zhou, et al.
BMC Psychiatry|December 5, 2014
Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED studyVinod H Srihari, Cenk Tek, Jessica Pollard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2024
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and DiagnosisHarrison K Tsai, Mark F Sabbagh, Meagan Montesion, et al.
Leukemia & Lymphoma|January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Clinical Epigenetics|October 17, 2017
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AMLLia Gore, Timothy J Triche, Jason E Farrar, et al.
Haematologica|June 24, 2017
Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Yimei Li, Marko Kavcic, et al.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Haematologica|February 1, 2024
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology GroupAndrew J Menssen, Chad A Hudson, Todd Alonzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 10, 2025
Genomic Profiling of Pediatric Mycosis Fungoides, Lymphomatoid Papulosis, and Primary Cutaneous Anaplastic Large Cell Lymphoma Identifies Recurrent Tyrosine Kinase Gene FusionsGrant M Fischer, Harrison K Tsai, Jennifer Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921Erica Brivio, Edoardo Pennesi, Marieke E Willemse, et al.
Pageof 3